JP2024517837A5 - - Google Patents
Info
- Publication number
- JP2024517837A5 JP2024517837A5 JP2023568058A JP2023568058A JP2024517837A5 JP 2024517837 A5 JP2024517837 A5 JP 2024517837A5 JP 2023568058 A JP2023568058 A JP 2023568058A JP 2023568058 A JP2023568058 A JP 2023568058A JP 2024517837 A5 JP2024517837 A5 JP 2024517837A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- alkyl
- halogen
- pharmaceutically acceptable
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184240P | 2021-05-05 | 2021-05-05 | |
| US63/184,240 | 2021-05-05 | ||
| PCT/US2022/027615 WO2022235754A1 (en) | 2021-05-05 | 2022-05-04 | Lactone and lactam containing compounds useful as immunomodulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517837A JP2024517837A (ja) | 2024-04-23 |
| JP2024517837A5 true JP2024517837A5 (enExample) | 2025-05-14 |
Family
ID=81984636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568058A Pending JP2024517837A (ja) | 2021-05-05 | 2022-05-04 | 免疫調節剤として有用なラクトンおよびラクタム含有化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240327389A1 (enExample) |
| EP (1) | EP4334308A1 (enExample) |
| JP (1) | JP2024517837A (enExample) |
| KR (1) | KR20240004801A (enExample) |
| CN (1) | CN117255789A (enExample) |
| WO (1) | WO2022235754A1 (enExample) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410690B1 (en) | 1995-06-07 | 2002-06-25 | Medarex, Inc. | Therapeutic compounds comprised of anti-Fc receptor antibodies |
| US5811097A (en) | 1995-07-25 | 1998-09-22 | The Regents Of The University Of California | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| US5922845A (en) | 1996-07-11 | 1999-07-13 | Medarex, Inc. | Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies |
| CN105705489B (zh) * | 2013-09-04 | 2019-04-26 | 百时美施贵宝公司 | 用作免疫调节剂的化合物 |
| US10745382B2 (en) * | 2015-10-15 | 2020-08-18 | Bristol-Myers Squibb Company | Compounds useful as immunomodulators |
| US10919852B2 (en) * | 2017-07-28 | 2021-02-16 | Chemocentryx, Inc. | Immunomodulator compounds |
| CN112041312A (zh) * | 2018-03-01 | 2020-12-04 | 百时美施贵宝公司 | 用作免疫调节剂的化合物 |
| US20210236476A1 (en) * | 2018-08-29 | 2021-08-05 | Chemocentryx, Inc. | Methods of treating cancer with small molecule pd-l1 inhibitors |
| BR112021025888A2 (pt) * | 2019-07-10 | 2022-04-26 | Chemocentryx Inc | Indanos como inibidores de pd-l1 |
| CN114761085A (zh) * | 2019-10-04 | 2022-07-15 | 百时美施贵宝公司 | 可用作免疫调节剂的化合物 |
-
2022
- 2022-05-04 KR KR1020237041380A patent/KR20240004801A/ko active Pending
- 2022-05-04 JP JP2023568058A patent/JP2024517837A/ja active Pending
- 2022-05-04 EP EP22728999.8A patent/EP4334308A1/en active Pending
- 2022-05-04 WO PCT/US2022/027615 patent/WO2022235754A1/en not_active Ceased
- 2022-05-04 US US18/499,791 patent/US20240327389A1/en active Pending
- 2022-05-04 CN CN202280032512.9A patent/CN117255789A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0315966D0 (en) | Compounds | |
| JP2022538923A5 (enExample) | ||
| CA2615022A1 (en) | Hcv ns3 protease inhibitors | |
| RU2009115963A (ru) | Производные оксадиазола, обладающие противовоспалительными и иммунодепрессантными свойствами | |
| PE20030417A1 (es) | Derivados de urea como antagonistas del receptor vainilloide | |
| JP2021523221A5 (enExample) | ||
| RU99105751A (ru) | Цитоксический аминосахар и родственные индолопирролокарбазольные производные сахаров | |
| RU2014153920A (ru) | Дигидронафтиридины и родственные соединения, подходящие в качестве ингибиторов киназ для лечения пролиферативных заболеваний | |
| NO20021399D0 (no) | Kazolinderivater og deres anvendelse som farmasöytika | |
| RU2009141982A (ru) | Пиримидиновые производные | |
| RU92004336A (ru) | Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты | |
| ATE123771T1 (de) | Stickstoff enthaltende heterozyklische verbindungen, ihre herstellung und verwendung. | |
| RU2009102252A (ru) | Хиноксалинилмакроциклические ингибиторы серинпротеазы вируса гепатита с | |
| PE20030703A1 (es) | Inhibidores de la 17b-hidroxiesteroide deshidrogenasa tipo 3 | |
| CA2445190A1 (en) | Indole, azaindole and related heterocyclic amidopiperazine derivatives | |
| ATE140698T1 (de) | Diazotierte heterocyclische derivate aus stickstoff, substituiert durch eine biphenylgruppe, ihre herstellung, und diese enthaltende pharmazeutische zubereitungen | |
| CA2545427A1 (en) | Selective kinase inhibitors | |
| CA2324418A1 (en) | Novel opiate compounds, methods of making and methods of use | |
| PE20060197A1 (es) | Heterociclos biciclicos como inhibidores de cinasa | |
| PE20061124A1 (es) | Compuestos y derivados de dibencil amina | |
| RU2010150345A (ru) | Производные хиназолина | |
| RU2011103207A (ru) | Производные хиназолина | |
| DE60142934D1 (de) | Pharmazeutische dopamin-glykokonjugat-zusammensetzungen und verfahren zu deren herstellung | |
| JP2020531526A5 (enExample) | ||
| JP2023532128A5 (enExample) |